Literature DB >> 19191862

Surgical results of patients after esophageal resection or extended gastrectomy for cancer of the esophagogastric junction.

G Schumacher1, S C Schmidt, N Schlechtweg, T Roesch, M Sacchi, V von Dossow, S S Chopra, J Pratschke, J Zhukova, J Stieler, P Thuss-Patience, P Neuhaus.   

Abstract

Precise classification of cancers of the esophagogastric junction according to Siewert may be difficult for the presence of Barrett's esophagus or hiatal hernia, which subsequently leads to a difficult choice of the surgical procedure of esophagectomy or gastrectomy. Ninety-six patients with such cancers were operated on in our department in 7 years. Twenty-nine patients (30.2%), classified as type I (group 1), underwent a transthoracic esophagectomy with gastric pull up. Sixty-seven patients (69.8%) classified as type II or III (group 2) underwent an extended gastrectomy. We compared the patients of both groups retrospectively for disease-free survival and postoperative complications. The general performance status of most patients was comparable in both groups and was assigned to the American Society of Anesthesiologists class II or III. Statistically significant differences between the groups were seen for the postoperative reintubation rate [group 1: 31.0% vs. group 2: 9.0% (P = 0.009)], median time for surgery [group 1: 6 (3.5-8.5) hours vs. group 2: 4.7 (2.2-11.5) hours (P = 0.001)], time in the intensive care unit [group 1: 6 (3-85) days vs. group 2: 3 (1-54) days (P = 0.001)], median hospitalization time [group 1: 23 (14-105) days vs. group 2: 18 (10-63) days (P = 0.018)]. No statistical difference was observed for the recurrence-free survival of 40% after 3 years (P = 0.311), the mortality rate, the morbidity rate (P = 0.108), surgical and respiratory complications, and the incidence of anastomotic leakage (P = 0.645). We conclude that in selected cases it may be possible to perform an extended gastrectomy for small type I cancers.

Entities:  

Mesh:

Year:  2009        PMID: 19191862     DOI: 10.1111/j.1442-2050.2008.00923.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  6 in total

1.  Esophagojejunal anastomosis leakage after total gastrectomy for esophagogastric junction adenocarcinoma: options of treatment.

Authors:  Fabio Carboni; Mario Valle; Orietta Federici; Giovanni Battista Levi Sandri; Ida Camperchioli; Rocco Lapenta; Daniela Assisi; Alfredo Garofalo
Journal:  J Gastrointest Oncol       Date:  2016-08

2.  Long-Term Quality of Life After Total Gastrectomy Versus Ivor Lewis Esophagectomy.

Authors:  E Jezerskyte; L M Saadeh; E R C Hagens; M A G Sprangers; L Noteboom; H W M van Laarhoven; W J Eshuis; M I van Berge Henegouwen; S S Gisbertz
Journal:  World J Surg       Date:  2020-03       Impact factor: 3.352

Review 3.  Epidemiology of esophageal cancer.

Authors:  Yuwei Zhang
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

Review 4.  Evidence-based approach to the treatment of esophagogastric junction tumors.

Authors:  Francisco Schlottmann; María A Casas; Daniela Molena
Journal:  World J Clin Oncol       Date:  2022-03-24

5.  Risk of Confusion: Detection of a Circular Thickness of the Wall in the Lower Part of the Esophagus.

Authors:  Achim Hochlehnert; Sylvie Lorenzen; Peter Hallscheidt; Jens Encke; Robert Ehehalt
Journal:  Gastroenterology Res       Date:  2011-07-20

6.  Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma.

Authors:  Joonas H Kauppila; Cecilia Ringborg; Asif Johar; Jesper Lagergren; Pernilla Lagergren
Journal:  Gastric Cancer       Date:  2017-08-29       Impact factor: 7.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.